36071-76-8

Basic information

• Product Name: (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one
• Synonyms: (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one
• CAS NO: 36071-76-8
• Molecular Weight: 516.764
• Mol File: 36071-76-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one(CAS DataBase Reference)
• NIST Chemistry Reference: (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one(36071-76-8)
• EPA Substance Registry System: (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one(36071-76-8)

Safety Data

• Hazardous Substances Data: 36071-76-8(Hazardous Substances Data)

Usage

Description

(3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one is a complex sterol compound belonging to the ergosterone family. It is characterized by the presence of a benzoyloxy group attached to the ergosta-8(14),22-dien-15-one backbone, which contributes to its potential pharmaceutical applications.

Uses

Used in Pharmaceutical Applications:
(3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one is used as a pharmaceutical agent for its anti-inflammatory, anti-fungal, and anti-tumor properties. Its chemical structure suggests that it may play a role in various biological processes, and further research on this compound could lead to the development of new drugs with therapeutic potential.
Used in Research and Development:
In the field of research and development, (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one is used as a subject of study to explore its potential applications in medicine. (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one's unique structure and properties make it an interesting candidate for the development of novel therapeutic agents.
Used in Drug Delivery Systems:
Similar to gallotannin, (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one could potentially be used in drug delivery systems to enhance its applications and efficacy. Various organic and metallic nanoparticles could be employed as carriers for this compound, aiming to improve its delivery, bioavailability, and therapeutic outcomes.
Please note that the provided materials do not specify any particular industry for the use of (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one, so the applications listed are general and based on the compound's described properties.

Upstream product

• 67-56-1 methanol 
• 5035-30-3 (3β,22E)-ergosta-5,7,22-trien-3-ol benzoate 
• 53639-76-2 (3β,5α,17β,22E)-ergosta-8,14,22-trien-3-ol benzoate 
• 36959-80-5 benzoate d'ergosterol B₃ 

Downstream Products

• 705926-28-9 (22E)-3β-hydroxyergosta-8(14),22-dien-15-one 
• 87530-88-9 benzoate d'aza-14a D-homo ergostadiene-8(14),22 ol-3β one-15 
• 87530-87-8 C₄₂H₅₅NO₅S 
• 53639-76-2 (3β,5α,17β,22E)-ergosta-8,14,22-trien-3-ol benzoate 
• 516-88-1 Ergosta-8(9),14(15),22(23)-trien-3β-ol 
• 117439-00-6 (3β,5α,24R,S)-Cholesta-8,14-diene-3,15,24-triol 3-benzoate 24-trifluoromethanesulfonate 
• 117438-87-6 (3β,5α,24R,S)-3-(Benzoyloxy)-24-(trifluoroacetoxy)cholest-8(14)-en-15-one 
• 117438-79-6 (3β,5α,24R,S)-Cholesta-8,14-diene-3,24-diol 3-benzoate 24-trifluoroacetate 
• 117151-66-3 (3β,5α,24R,S)-24-<(tert-Butyldimethylsilyl)oxy>cholesta-8,14-dien-3-ol benzoate 
• 117168-34-0 (3β,5α,22R,S)-3-(Benzoyloxy)-22-hydroxycholest-8(14)-ene-15,24-dione 
• 117160-80-2 (3β,5α-22E)-3-(Benzoyloxy)cholesta-8(14),22-diene-15,24-dione 
• 117151-69-6 (3β,5α)-3-(Benzoyloxy)cholest-8(14)-ene-15,24-dione 
• 117438-91-2 Benzoic acid (3S,5S,9R,10S,13R,17R)-17-((R)-4-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-15-oxo-2,3,4,5,6,7,9,10,11,12,13,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 
• 117439-02-8 Benzoic acid (3S,5S,10S,13R,17R)-17-((R)-4-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,10,11,12,13,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 

Relevant articles and documents

Improved preparation of (3β,5α,14α)-3-hydroxy-14-methylcholest-7-en-15-one. Synthesis of ergostenone and 20α-(hydroxymethyl)pregnenone analogues

-